SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-18-000067
Filing Date
2018-05-09
Accepted
2018-05-09 17:18:11
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq11810q.htm 10-Q 996608
2 EXHIBIT 10.1 rvnc-q118exhibit101.htm EX-10.1 548811
3 EXHIBIT 31.1 rvnc-q118exhibit311.htm EX-31.1 13578
4 EXHIBIT 31.2 rvnc-q118exhibit312.htm EX-31.2 13475
5 EXHIBIT 32.1 rvnc-q118exhibit321.htm EX-32.1 6236
6 EXHIBIT 32.2 rvnc-q118exhibit322.htm EX-32.2 6261
  Complete submission text file 0001479290-18-000067.txt   4678162

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rvnc-20180331.xml EX-101.INS 717469
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20180331.xsd EX-101.SCH 33571
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20180331_cal.xml EX-101.CAL 52467
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20180331_def.xml EX-101.DEF 153012
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20180331_lab.xml EX-101.LAB 424350
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20180331_pre.xml EX-101.PRE 251741
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 18819485
SIC: 2834 Pharmaceutical Preparations